Clinical Trials Browser

Phase 3 × Cardiotoxicity × Breast × Clear all

NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Phase 3 Recruiting

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

NCT05728632 2023-02-23

CONTROL

Phase 3 Unknown

Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse, Ventricular Dysfunction, Left, Cardiotoxicity

NCT02236806 2022-02-01

SAFE

Phase 3 Unknown

Breast Neoplasms, Cardiotoxicity

NCT01724450 2018-02-05

Ceccy

Phase 3 Completed

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT00459771 2014-12-02

Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity

Phase 3 Completed

Breast Neoplasms, Cardiotoxicity

NCT00016276 2013-01-16

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Phase 3 Terminated

Breast Neoplasms, Inflammatory Breast Neoplasms, Cardiotoxicity

NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Phase 3 Unknown

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity